WATERS CORP /DE/ is 34.3x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($35.47 B vs $1.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EYPT | WAT |
|---|---|---|
| Market cap | $1.03 B | $35.47 B |
| US-listed rank | #2607 | #416 |
| Revenue (latest FY) | $31.37M | $3.17B |
| Net income (latest FY) | -$231.96M | $642.63M |
| Net margin | -739.4% | 20.3% |
| P/E (trailing FY) | - | 55.2 |
| SEC filings | 1,308 | 1,887 |
WATERS CORP /DE/ is 34.3x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($35.47 B vs $1.03 B).
In their latest fiscal years, EyePoint Pharmaceuticals, Inc. reported $31.37M in revenue while WATERS CORP /DE/ reported $3.17B.
Full pages: EyePoint Pharmaceuticals, Inc. and WATERS CORP /DE/, or browse the full rankings.